Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective [Hardcover]

This book reviews existing evidence and new ideas on how best to promote pharmaceutical innovation.This book reviews existing evidence and new ideas about how to best promote pharmaceutical innovation. It covers specific topics such as the methods used to promote development of new vaccines, the drugs used to treat uncommon diseases, and the drugs for treating diseases that are prevalent in low-income countries.This book reviews existing evidence and new ideas about how to best promote pharmaceutical innovation. It covers specific topics such as the methods used to promote development of new vaccines, the drugs used to treat uncommon diseases, and the drugs for treating diseases that are prevalent in low-income countries.The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.1. Introduction Frank Sloan and Chee-Ruey Hsieh; Part I. The Industry Structure of Pharmaceutical Innovation: 2. The pharmaceutical sector in health care Uwe Reinhardt; 3. The economics of research and development in the pharmaceutical industry William Comanor; Part II. Structuring Incentives for Research and Development: 4. Drugs for neglected diseases: nel7